First results from the international randomized SENOMAC trial - Jana de Boniface, Karolinska Institutet
326037
CDK 4-6 inhibitor switching patterns in Swedish patients with metastatic breast cancer
276544
HER2-low tumors from a locoregional perspective
151040
Genomic characterization and molecular predictive biomarkers for chemotherapy in a RWD population with mTNC
517269
Har fysisk träning en egen onkologisk effekt
153344